{
  "DOI": "10.1038/hdy.2010.42",
  "ISSN": [
    "0018-067X",
    "1365-2540"
  ],
  "URL": "http://dx.doi.org/10.1038/hdy.2010.42",
  "alternative-id": [
    "BFhdy201042"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Claes",
      "given": "B",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Buysschaert",
      "given": "I",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lambrechts",
      "given": "D",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Heredity"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2010,
        4,
        14
      ]
    ],
    "date-time": "2010-04-14T09:28:23Z",
    "timestamp": 1271237303000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        3,
        25
      ]
    ],
    "date-time": "2024-03-25T20:25:44Z",
    "timestamp": 1711398344000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T05:09:42Z",
    "timestamp": 1713935382204
  },
  "is-referenced-by-count": 21,
  "issn-type": [
    {
      "type": "print",
      "value": "0018-067X"
    },
    {
      "type": "electronic",
      "value": "1365-2540"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2010,
        4,
        14
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2010,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2010,
            4,
            14
          ]
        ],
        "date-time": "2010-04-14T00:00:00Z",
        "timestamp": 1271203200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/hdy201042.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/hdy201042",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/hdy201042.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "152-160",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2010,
        4,
        14
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        4,
        14
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1073/pnas.0600645103",
      "author": "R Agrelo",
      "doi-asserted-by": "crossref",
      "first-page": "8822",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFhdy201042_CR1",
      "unstructured": "Agrelo R, Cheng WH, Setien F, Ropero S, Espada J, Fraga MF et al. (2006). Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci USA 103: 8822–8827.",
      "volume": "103",
      "year": "2006"
    },
    {
      "DOI": "10.1093/emboj/cdg604",
      "author": "E Ballestar",
      "doi-asserted-by": "crossref",
      "first-page": "6335",
      "journal-title": "EMBO J",
      "key": "BFhdy201042_CR2",
      "unstructured": "Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, Espada J et al. (2003). Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 22: 6335–6345.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1002/0470862637.ch17",
      "author": "SB Baylin",
      "doi-asserted-by": "crossref",
      "first-page": "226",
      "journal-title": "Novartis Found Symp",
      "key": "BFhdy201042_CR3",
      "unstructured": "Baylin SB (2004). Reversal of gene silencing as a therapeutic target for cancer--roles for DNA methylation and its interdigitation with chromatin. Novartis Found Symp 259: 226–233;discussion 234–237, 285–288.",
      "volume": "259",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.95.20.11891",
      "author": "SA Belinsky",
      "doi-asserted-by": "crossref",
      "first-page": "11891",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFhdy201042_CR4",
      "unstructured": "Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E et al. (1998). Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95: 11891–11896.",
      "volume": "95",
      "year": "1998"
    },
    {
      "DOI": "10.1038/sj.onc.1210072",
      "author": "A Beltran",
      "doi-asserted-by": "crossref",
      "first-page": "2791",
      "journal-title": "Oncogene",
      "key": "BFhdy201042_CR5",
      "unstructured": "Beltran A, Parikh S, Liu Y, Cuevas BD, Johnson GL, Futscher BW et al. (2007). Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors. Oncogene 26: 2791–2798.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1186/bcr1522",
      "author": "V Birgisdottir",
      "doi-asserted-by": "crossref",
      "first-page": "R38",
      "journal-title": "Breast Cancer Res",
      "key": "BFhdy201042_CR6",
      "unstructured": "Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE (2006). Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8: R38.",
      "volume": "8",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1582-4934.2008.00515.x",
      "author": "I Buysschaert",
      "doi-asserted-by": "crossref",
      "first-page": "2533",
      "issue": "6B",
      "journal-title": "J Cell Mol Med",
      "key": "BFhdy201042_CR7",
      "unstructured": "Buysschaert I, Schmidt T, Roncal C, Carmeliet P, Lambrechts D (2008). Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis. J Cell Mol Med 12 (6B): 2533–2551.",
      "volume": "12",
      "year": "2008"
    },
    {
      "author": "P Cairns",
      "first-page": "2727",
      "journal-title": "Clin Cancer Res",
      "key": "BFhdy201042_CR8",
      "unstructured": "Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M et al. (2001). Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 7: 2727–2730.",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1038/5047",
      "author": "EE Cameron",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "journal-title": "Nat Genet",
      "key": "BFhdy201042_CR9",
      "unstructured": "Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999). Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103–107.",
      "volume": "21",
      "year": "1999"
    },
    {
      "DOI": "10.1038/nature04478",
      "author": "P Carmeliet",
      "doi-asserted-by": "crossref",
      "first-page": "932",
      "journal-title": "Nature",
      "key": "BFhdy201042_CR10",
      "unstructured": "Carmeliet P (2005). Angiogenesis in life, disease and medicine. Nature 438: 932–936.",
      "volume": "438",
      "year": "2005"
    },
    {
      "DOI": "10.1038/bjc.1988.89",
      "author": "BI Carr",
      "doi-asserted-by": "crossref",
      "first-page": "395",
      "journal-title": "Br J Cancer",
      "key": "BFhdy201042_CR11",
      "unstructured": "Carr BI, Rahbar S, Asmeron Y, Riggs A, Winberg CD (1988). Carcinogenicity and haemoglobin synthesis induction by cytidine analogues. Br J Cancer 57: 395–402.",
      "volume": "57",
      "year": "1988"
    },
    {
      "DOI": "10.1093/jnci/95.5.399",
      "author": "JC Cheng",
      "doi-asserted-by": "crossref",
      "first-page": "399",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFhdy201042_CR12",
      "unstructured": "Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE et al. (2003). Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst 95: 399–409.",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.febslet.2008.10.048",
      "author": "CW Chou",
      "doi-asserted-by": "crossref",
      "first-page": "4059",
      "journal-title": "FEBS Lett",
      "key": "BFhdy201042_CR13",
      "unstructured": "Chou CW, Chen CC (2008). HDAC inhibition upregulates the expression of angiostatic ADAMTS1. FEBS Lett 582: 4059–4065.",
      "volume": "582",
      "year": "2008"
    },
    {
      "DOI": "10.1128/MCB.25.13.5429-5444.2005",
      "author": "Y Dai",
      "doi-asserted-by": "crossref",
      "first-page": "5429",
      "journal-title": "Mol Cell Biol",
      "key": "BFhdy201042_CR14",
      "unstructured": "Dai Y, Rahmani M, Dent P, Grant S (2005). Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Mol Cell Biol 25: 5429–5444.",
      "volume": "25",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.onc.1205108",
      "author": "CF Deroanne",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "journal-title": "Oncogene",
      "key": "BFhdy201042_CR15",
      "unstructured": "Deroanne CF, Bonjean K, Servotte S, Devy L, Colige A, Clausse N et al. (2002). Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 21: 427–436.",
      "volume": "21",
      "year": "2002"
    },
    {
      "DOI": "10.1128/MCB.25.5.1608-1619.2005",
      "author": "H Duan",
      "doi-asserted-by": "crossref",
      "first-page": "1608",
      "journal-title": "Mol Cell Biol",
      "key": "BFhdy201042_CR16",
      "unstructured": "Duan H, Heckman CA, Boxer LM (2005). Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol 25: 1608–1619.",
      "volume": "25",
      "year": "2005"
    },
    {
      "DOI": "10.1126/science.1083557",
      "author": "A Eden",
      "doi-asserted-by": "crossref",
      "first-page": "455",
      "journal-title": "Science",
      "key": "BFhdy201042_CR17",
      "unstructured": "Eden A, Gaudet F, Waghmare A, Jaenisch R (2003). Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300: 455.",
      "volume": "300",
      "year": "2003"
    },
    {
      "DOI": "10.1002/pros.21038",
      "author": "J Ellinger",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "journal-title": "Prostate",
      "key": "BFhdy201042_CR18",
      "unstructured": "Ellinger J, Kahl P, von der Gathen J, Rogenhofer S, Heukamp LC, Gutgemann I et al. (2009). Global levels of histone modifications predict prostate cancer recurrence. Prostate 70: 61–69.",
      "volume": "70",
      "year": "2009"
    },
    {
      "author": "M Esteller",
      "first-page": "4515",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR19",
      "unstructured": "Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG (1998). Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 58: 4515–4518.",
      "volume": "58",
      "year": "1998"
    },
    {
      "DOI": "10.1093/jnci/94.1.26",
      "author": "M Esteller",
      "doi-asserted-by": "crossref",
      "first-page": "26",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFhdy201042_CR20",
      "unstructured": "Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B et al. (2002). Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 94: 26–32.",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJM200011093431901",
      "author": "M Esteller",
      "doi-asserted-by": "crossref",
      "first-page": "1350",
      "journal-title": "N Engl J Med",
      "key": "BFhdy201042_CR21",
      "unstructured": "Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V et al. (2000). Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350–1354.",
      "volume": "343",
      "year": "2000"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-2733",
      "author": "MJ Fackler",
      "doi-asserted-by": "crossref",
      "first-page": "3306",
      "issue": "11 Part 1",
      "journal-title": "Clin Cancer Res",
      "key": "BFhdy201042_CR22",
      "unstructured": "Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T et al. (2006). Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 12 (11 Part 1): 3306–3310.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nature05919",
      "author": "AP Feinberg",
      "doi-asserted-by": "crossref",
      "first-page": "433",
      "journal-title": "Nature",
      "key": "BFhdy201042_CR23",
      "unstructured": "Feinberg AP (2007). Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433–440.",
      "volume": "447",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nrc1279",
      "author": "AP Feinberg",
      "doi-asserted-by": "crossref",
      "first-page": "143",
      "journal-title": "Nat Rev Cancer",
      "key": "BFhdy201042_CR24",
      "unstructured": "Feinberg AP, Tycko B (2004). The history of cancer epigenetics. Nat Rev Cancer 4: 143–153.",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1056/NEJMoa0900212",
      "author": "PC Fong",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "journal-title": "N Engl J Med",
      "key": "BFhdy201042_CR25",
      "unstructured": "Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M et al. (2009). Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123–134.",
      "volume": "361",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng1531",
      "author": "MF Fraga",
      "doi-asserted-by": "crossref",
      "first-page": "391",
      "journal-title": "Nat Genet",
      "key": "BFhdy201042_CR26",
      "unstructured": "Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G et al. (2005). Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37: 391–400.",
      "volume": "37",
      "year": "2005"
    },
    {
      "DOI": "10.1002/jcb.10286",
      "author": "TM Geiman",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "journal-title": "J Cell Biochem",
      "key": "BFhdy201042_CR27",
      "unstructured": "Geiman TM, Robertson KD (2002). Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together? J Cell Biochem 87: 117–125.",
      "volume": "87",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMra0708473",
      "author": "PD Gluckman",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "journal-title": "N Engl J Med",
      "key": "BFhdy201042_CR28",
      "unstructured": "Gluckman PD, Hanson MA, Cooper C, Thornburg KL (2008). Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359: 61–73.",
      "volume": "359",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-0883",
      "author": "JA Gollob",
      "doi-asserted-by": "crossref",
      "first-page": "4619",
      "journal-title": "Clin Cancer Res",
      "key": "BFhdy201042_CR29",
      "unstructured": "Gollob JA, Sciambi CJ, Peterson BL, Richmond T, Thoreson M, Moran K et al. (2006). Phase I trial of sequential low-dose 5-aza-2′-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. Clin Cancer Res 12: 4619–4627.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s00277-005-0004-1",
      "author": "B Hackanson",
      "doi-asserted-by": "crossref",
      "first-page": "32",
      "issue": "Suppl 1",
      "journal-title": "Ann Hematol",
      "key": "BFhdy201042_CR30",
      "unstructured": "Hackanson B, Robbel C, Wijermans P, Lubbert M (2005). In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies. Ann Hematol 84 (Suppl 1): 32–38.",
      "volume": "84",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0092-8674(00)81683-9",
      "author": "D Hanahan",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "journal-title": "Cell",
      "key": "BFhdy201042_CR31",
      "unstructured": "Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell 100: 57–70.",
      "volume": "100",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJMoa043331",
      "author": "ME Hegi",
      "doi-asserted-by": "crossref",
      "first-page": "997",
      "journal-title": "N Engl J Med",
      "key": "BFhdy201042_CR32",
      "unstructured": "Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M et al. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997–1003.",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-1609",
      "author": "DM Hellebrekers",
      "doi-asserted-by": "crossref",
      "first-page": "10770",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR33",
      "unstructured": "Hellebrekers DM, Castermans K, Vire E, Dings RP, Hoebers NT, Mayo KH et al. (2006a). Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 66: 10770–10777.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-05-0417",
      "author": "DM Hellebrekers",
      "doi-asserted-by": "crossref",
      "first-page": "467",
      "journal-title": "Mol Cancer Ther",
      "key": "BFhdy201042_CR34",
      "unstructured": "Hellebrekers DM, Jair KW, Vire E, Eguchi S, Hoebers NT, Fraga MF et al. (2006b). Angiostatic activity of DNA methyltransferase inhibitors. Mol Cancer Ther 5: 467–475.",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-3032",
      "author": "DM Hellebrekers",
      "doi-asserted-by": "crossref",
      "first-page": "4138",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR35",
      "unstructured": "Hellebrekers DM, Melotte V, Vire E, Langenkamp E, Molema G, Fuks F et al. (2007). Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res 67: 4138–4148.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMra023075",
      "author": "JG Herman",
      "doi-asserted-by": "crossref",
      "first-page": "2042",
      "journal-title": "N Engl J Med",
      "key": "BFhdy201042_CR36",
      "unstructured": "Herman JG, Baylin SB (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042–2054.",
      "volume": "349",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-1284",
      "author": "RA Hinshelwood",
      "doi-asserted-by": "crossref",
      "first-page": "11517",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR37",
      "unstructured": "Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B et al. (2007). Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 67: 11517–11527.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.jcbfm.9600304",
      "author": "CJ Hu",
      "doi-asserted-by": "crossref",
      "first-page": "1519",
      "journal-title": "J Cereb Blood Flow Metab",
      "key": "BFhdy201042_CR38",
      "unstructured": "Hu CJ, Chen SD, Yang DI, Lin TN, Chen CM, Huang TH et al. (2006). Promoter region methylation and reduced expression of thrombospondin-1 after oxygen-glucose deprivation in murine cerebral endothelial cells. J Cereb Blood Flow Metab 26: 1519–1526.",
      "volume": "26",
      "year": "2006"
    },
    {
      "DOI": "10.1073/pnas.94.9.4681",
      "author": "L Jackson-Grusby",
      "doi-asserted-by": "crossref",
      "first-page": "4681",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFhdy201042_CR39",
      "unstructured": "Jackson-Grusby L, Laird PW, Magge SN, Moeller BJ, Jaenisch R (1997). Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc Natl Acad Sci USA 94: 4681–4685.",
      "volume": "94",
      "year": "1997"
    },
    {
      "DOI": "10.1093/jnci/93.22.1747",
      "author": "C Jeronimo",
      "doi-asserted-by": "crossref",
      "first-page": "1747",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFhdy201042_CR40",
      "unstructured": "Jeronimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG et al. (2001). Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 93: 1747–1752.",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.1038/nrg816",
      "author": "PA Jones",
      "doi-asserted-by": "crossref",
      "first-page": "415",
      "journal-title": "Nat Rev Genet",
      "key": "BFhdy201042_CR41",
      "unstructured": "Jones PA, Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415–428.",
      "volume": "3",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.cell.2007.01.029",
      "author": "PA Jones",
      "doi-asserted-by": "crossref",
      "first-page": "683",
      "journal-title": "Cell",
      "key": "BFhdy201042_CR42",
      "unstructured": "Jones PA, Baylin SB (2007). The epigenomics of cancer. Cell 128: 683–692.",
      "volume": "128",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.onc.1207852",
      "author": "J Joseph",
      "doi-asserted-by": "crossref",
      "first-page": "6304",
      "journal-title": "Oncogene",
      "key": "BFhdy201042_CR43",
      "unstructured": "Joseph J, Mudduluru G, Antony S, Vashistha S, Ajitkumar P, Somasundaram K (2004). Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 23: 6304–6315.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.96.24.14007",
      "author": "AR Karpf",
      "doi-asserted-by": "crossref",
      "first-page": "14007",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFhdy201042_CR44",
      "unstructured": "Karpf AR, Peterson PW, Rawlins JT, Dalley BK, Yang Q, Albertsen H et al. (1999). Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc Natl Acad Sci USA 96: 14007–14012.",
      "volume": "96",
      "year": "1999"
    },
    {
      "DOI": "10.1056/NEJMra0706596",
      "author": "RS Kerbel",
      "doi-asserted-by": "crossref",
      "first-page": "2039",
      "journal-title": "N Engl J Med",
      "key": "BFhdy201042_CR45",
      "unstructured": "Kerbel RS (2008). Tumor angiogenesis. N Engl J Med 358: 2039–2049.",
      "volume": "358",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ncponc1238",
      "author": "O Khan",
      "doi-asserted-by": "crossref",
      "first-page": "714",
      "journal-title": "Nat Clin Pract Oncol",
      "key": "BFhdy201042_CR46",
      "unstructured": "Khan O, La Thangue NB (2008). Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas. Nat Clin Pract Oncol 5: 714–726.",
      "volume": "5",
      "year": "2008"
    },
    {
      "DOI": "10.1038/86507",
      "author": "MS Kim",
      "doi-asserted-by": "crossref",
      "first-page": "437",
      "journal-title": "Nat Med",
      "key": "BFhdy201042_CR47",
      "unstructured": "Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW et al. (2001). Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7: 437–443.",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.cell.2007.02.005",
      "author": "T Kouzarides",
      "doi-asserted-by": "crossref",
      "first-page": "693",
      "journal-title": "Cell",
      "key": "BFhdy201042_CR48",
      "unstructured": "Kouzarides T (2007). Chromatin modifications and their function. Cell 128: 693–705.",
      "volume": "128",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-2694",
      "author": "MN Lee",
      "doi-asserted-by": "crossref",
      "first-page": "832",
      "journal-title": "Clin Cancer Res",
      "key": "BFhdy201042_CR49",
      "unstructured": "Lee MN, Tseng RC, Hsu HS, Chen JY, Tzao C, Ho WL et al. (2007). Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer. Clin Cancer Res 13: 832–838.",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.onc.1202663",
      "author": "Q Li",
      "doi-asserted-by": "crossref",
      "first-page": "3284",
      "journal-title": "Oncogene",
      "key": "BFhdy201042_CR50",
      "unstructured": "Li Q, Ahuja N, Burger PC, Issa JP (1999). Methylation and silencing of the thrombospondin-1 promoter in human cancer. Oncogene 18: 3284–3289.",
      "volume": "18",
      "year": "1999"
    },
    {
      "author": "G Liang",
      "first-page": "961",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR51",
      "unstructured": "Liang G, Gonzales FA, Jones PA, Orntoft TF, Thykjaer T (2002). Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res 62: 961–966.",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/djp131",
      "author": "V Melotte",
      "doi-asserted-by": "crossref",
      "first-page": "916",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFhdy201042_CR52",
      "unstructured": "Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA et al. (2009). N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 101: 916–927.",
      "volume": "101",
      "year": "2009"
    },
    {
      "DOI": "10.1124/mol.65.3.520",
      "author": "M Michaelis",
      "doi-asserted-by": "crossref",
      "first-page": "520",
      "journal-title": "Mol Pharmacol",
      "key": "BFhdy201042_CR53",
      "unstructured": "Michaelis M, Michaelis UR, Fleming I, Suhan T, Cinatl J, Blaheta RA et al. (2004). Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol 65: 520–527.",
      "volume": "65",
      "year": "2004"
    },
    {
      "DOI": "10.1097/00001813-199704000-00008",
      "author": "RL Momparler",
      "doi-asserted-by": "crossref",
      "first-page": "358",
      "journal-title": "Anticancer Drugs",
      "key": "BFhdy201042_CR54",
      "unstructured": "Momparler RL, Bouffard DY, Momparler LF, Dionne J, Belanger K, Ayoub J (1997). Pilot phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer. Anticancer Drugs 8: 358–368.",
      "volume": "8",
      "year": "1997"
    },
    {
      "DOI": "10.1093/bfgp/1.4.342",
      "author": "M Moore",
      "doi-asserted-by": "crossref",
      "first-page": "342",
      "journal-title": "Brief Funct Genomic Proteomic",
      "key": "BFhdy201042_CR55",
      "unstructured": "Moore M, Ullman C (2003). Recent developments in the engineering of zinc finger proteins. Brief Funct Genomic Proteomic 1: 342–355.",
      "volume": "1",
      "year": "2003"
    },
    {
      "author": "HM Muller",
      "first-page": "7641",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR56",
      "unstructured": "Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E et al. (2003). DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63: 7641–7645.",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2088",
      "author": "A Munshi",
      "doi-asserted-by": "crossref",
      "first-page": "4912",
      "journal-title": "Clin Cancer Res",
      "key": "BFhdy201042_CR57",
      "unstructured": "Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL et al. (2005). Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 11: 4912–4922.",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-06-0022",
      "author": "A Munshi",
      "doi-asserted-by": "crossref",
      "first-page": "1967",
      "journal-title": "Mol Cancer Ther",
      "key": "BFhdy201042_CR58",
      "unstructured": "Munshi A, Tanaka T, Hobbs ML, Tucker SL, Richon VM, Meyn RE (2006). Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther 5: 1967–1974.",
      "volume": "5",
      "year": "2006"
    },
    {
      "author": "CT Nguyen",
      "first-page": "6456",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR59",
      "unstructured": "Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G et al. (2002). Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 62: 6456–6461.",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1038/nrclinonc.2009.111",
      "author": "N Normanno",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "BFhdy201042_CR60",
      "unstructured": "Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F (2009). Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol 6: 519–527.",
      "volume": "6",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.bjc.6690628",
      "author": "PD Pharoah",
      "doi-asserted-by": "crossref",
      "first-page": "1968",
      "journal-title": "Br J Cancer",
      "key": "BFhdy201042_CR61",
      "unstructured": "Pharoah PD, Day NE, Caldas C (1999). Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 80: 1968–1973.",
      "volume": "80",
      "year": "1999"
    },
    {
      "DOI": "10.1200/JCO.2005.03.4074",
      "author": "FJ Reu",
      "doi-asserted-by": "crossref",
      "first-page": "3771",
      "journal-title": "J Clin Oncol",
      "key": "BFhdy201042_CR62",
      "unstructured": "Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N et al. (2006). Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. J Clin Oncol 24: 3771–3779.",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1464-410X.2006.06376.x",
      "author": "BI Rini",
      "doi-asserted-by": "crossref",
      "first-page": "756",
      "journal-title": "BJU Int",
      "key": "BFhdy201042_CR63",
      "unstructured": "Rini BI, Jaeger E, Weinberg V, Sein N, Chew K, Fong K et al. (2006). Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. BJU Int 98: 756–762.",
      "volume": "98",
      "year": "2006"
    },
    {
      "author": "P Rocchi",
      "first-page": "1139",
      "journal-title": "Oncol Rep",
      "key": "BFhdy201042_CR64",
      "unstructured": "Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F et al. (2005). p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Oncol Rep 13: 1139–1144.",
      "volume": "13",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ijc.23608",
      "author": "A Rojas",
      "doi-asserted-by": "crossref",
      "first-page": "14",
      "journal-title": "Int J Cancer",
      "key": "BFhdy201042_CR65",
      "unstructured": "Rojas A, Meherem S, Kim YH, Washington MK, Willis JE, Markowitz SD et al. (2008). The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Int J Cancer 123: 14–21.",
      "volume": "123",
      "year": "2008"
    },
    {
      "DOI": "10.1161/01.RES.0000037983.07158.B1",
      "author": "L Rossig",
      "doi-asserted-by": "crossref",
      "first-page": "837",
      "journal-title": "Circ Res",
      "key": "BFhdy201042_CR66",
      "unstructured": "Rossig L, Li H, Fisslthaler B, Urbich C, Fleming I, Forstermann U et al. (2002). Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ Res 91: 837–844.",
      "volume": "91",
      "year": "2002"
    },
    {
      "DOI": "10.1084/jem.20042097",
      "author": "L Rossig",
      "doi-asserted-by": "crossref",
      "first-page": "1825",
      "journal-title": "J Exp Med",
      "key": "BFhdy201042_CR67",
      "unstructured": "Rossig L, Urbich C, Bruhl T, Dernbach E, Heeschen C, Chavakis E et al. (2005). Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 201: 1825–1835.",
      "volume": "201",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ccr.2006.04.020",
      "author": "Y Saito",
      "doi-asserted-by": "crossref",
      "first-page": "435",
      "journal-title": "Cancer Cell",
      "key": "BFhdy201042_CR68",
      "unstructured": "Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA et al. (2006). Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435–443.",
      "volume": "9",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nrg2295",
      "author": "H Sasaki",
      "doi-asserted-by": "crossref",
      "first-page": "129",
      "journal-title": "Nat Rev Genet",
      "key": "BFhdy201042_CR69",
      "unstructured": "Sasaki H, Matsui Y (2008). Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat Rev Genet 9: 129–140.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2006.06.3024",
      "author": "MK Schmidt",
      "doi-asserted-by": "crossref",
      "first-page": "64",
      "journal-title": "J Clin Oncol",
      "key": "BFhdy201042_CR70",
      "unstructured": "Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT et al. (2007). Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol 25: 64–69.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-0669",
      "author": "DS Schrump",
      "doi-asserted-by": "crossref",
      "first-page": "5777",
      "journal-title": "Clin Cancer Res",
      "key": "BFhdy201042_CR71",
      "unstructured": "Schrump DS, Fischette MR, Nguyen DM, Zhao M, Li X, Kunst TF et al. (2006). Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura. Clin Cancer Res 12: 5777–5785.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nature03672",
      "author": "DB Seligson",
      "doi-asserted-by": "crossref",
      "first-page": "1262",
      "journal-title": "Nature",
      "key": "BFhdy201042_CR72",
      "unstructured": "Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M et al. (2005). Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435: 1262–1266.",
      "volume": "435",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0145-2126(02)00222-9",
      "author": "S Shaker",
      "doi-asserted-by": "crossref",
      "first-page": "437",
      "journal-title": "Leuk Res",
      "key": "BFhdy201042_CR73",
      "unstructured": "Shaker S, Bernstein M, Momparler LF, Momparler RL (2003). Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. Leuk Res 27: 437–444.",
      "volume": "27",
      "year": "2003"
    },
    {
      "DOI": "10.1128/MCB.25.13.5404-5416.2005",
      "author": "S Shetty",
      "doi-asserted-by": "crossref",
      "first-page": "5404",
      "journal-title": "Mol Cell Biol",
      "key": "BFhdy201042_CR74",
      "unstructured": "Shetty S, Graham BA, Brown JG, Hu X, Vegh-Yarema N, Harding G et al. (2005). Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol Cell Biol 25: 5404–5416.",
      "volume": "25",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2002.04.117",
      "author": "LR Silverman",
      "doi-asserted-by": "crossref",
      "first-page": "2429",
      "journal-title": "J Clin Oncol",
      "key": "BFhdy201042_CR75",
      "unstructured": "Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R et al. (2002). Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20: 2429–2440.",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ncponc0347",
      "author": "LR Silverman",
      "doi-asserted-by": "crossref",
      "first-page": "S12",
      "issue": "Suppl 1",
      "journal-title": "Nat Clin Pract Oncol",
      "key": "BFhdy201042_CR76",
      "unstructured": "Silverman LR, Mufti GJ (2005). Methylation inhibitor therapy in the treatment of myelodysplastic syndrome. Nat Clin Pract Oncol 2 (Suppl 1): S12–S23.",
      "volume": "2",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.tig.2007.07.005",
      "author": "LT Smith",
      "doi-asserted-by": "crossref",
      "first-page": "449",
      "journal-title": "Trends Genet",
      "key": "BFhdy201042_CR77",
      "unstructured": "Smith LT, Otterson GA, Plass C (2007). Unraveling the epigenetic code of cancer for therapy. Trends Genet 23: 449–456.",
      "volume": "23",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMra0801289",
      "author": "C Sotiriou",
      "doi-asserted-by": "crossref",
      "first-page": "790",
      "journal-title": "N Engl J Med",
      "key": "BFhdy201042_CR78",
      "unstructured": "Sotiriou C, Pusztai L (2009). Gene-expression signatures in breast cancer. N Engl J Med 360: 790–800.",
      "volume": "360",
      "year": "2009"
    },
    {
      "DOI": "10.1038/47412",
      "author": "BD Strahl",
      "doi-asserted-by": "crossref",
      "first-page": "41",
      "journal-title": "Nature",
      "key": "BFhdy201042_CR79",
      "unstructured": "Strahl BD, Allis CD (2000). The language of covalent histone modifications. Nature 403: 41–45.",
      "volume": "403",
      "year": "2000"
    },
    {
      "DOI": "10.1038/sj.onc.1202540",
      "author": "G Strathdee",
      "doi-asserted-by": "crossref",
      "first-page": "2335",
      "journal-title": "Oncogene",
      "key": "BFhdy201042_CR80",
      "unstructured": "Strathdee G, MacKean MJ, Illand M, Brown R (1999). A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene 18: 2335–2341.",
      "volume": "18",
      "year": "1999"
    },
    {
      "DOI": "10.1038/nature07943",
      "author": "MR Stratton",
      "doi-asserted-by": "crossref",
      "first-page": "719",
      "journal-title": "Nature",
      "key": "BFhdy201042_CR81",
      "unstructured": "Stratton MR, Campbell PJ, Futreal PA (2009). The cancer genome. Nature 458: 719–724.",
      "volume": "458",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng892",
      "author": "H Suzuki",
      "doi-asserted-by": "crossref",
      "first-page": "141",
      "journal-title": "Nat Genet",
      "key": "BFhdy201042_CR82",
      "unstructured": "Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP et al. (2002). A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141–149.",
      "volume": "31",
      "year": "2002"
    },
    {
      "DOI": "10.2174/1570160043377358",
      "author": "M Szyf",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "journal-title": "Curr Pharmacogenomics",
      "key": "BFhdy201042_CR83",
      "unstructured": "Szyf M (2004). Toward a discipline of pharmacoepigenomics. Curr Pharmacogenomics 2: 357–377.",
      "volume": "2",
      "year": "2004"
    },
    {
      "DOI": "10.4161/epi.3.3.6387",
      "author": "T Tapia",
      "doi-asserted-by": "crossref",
      "first-page": "157",
      "journal-title": "Epigenetics",
      "key": "BFhdy201042_CR84",
      "unstructured": "Tapia T, Smalley SV, Kohen P, Munoz A, Solis LM, Corvalan A et al. (2008). Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors. Epigenetics 3: 157–163.",
      "volume": "3",
      "year": "2008"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-08-2976",
      "author": "NV Verbisck",
      "doi-asserted-by": "crossref",
      "first-page": "5546",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR85",
      "unstructured": "Verbisck NV, Costa ET, Costa FF, Cavalher FP, Costa MD, Muras A et al. (2009). ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis. Cancer Res 69: 5546–5552.",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.2119/2007-00096.Wettergren",
      "author": "Y Wettergren",
      "doi-asserted-by": "crossref",
      "first-page": "412",
      "journal-title": "Mol Med",
      "key": "BFhdy201042_CR86",
      "unstructured": "Wettergren Y, Odin E, Nilsson S, Carlsson G, Gustavsson B (2008). p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer. Mol Med 14: 412–421.",
      "volume": "14",
      "year": "2008"
    },
    {
      "author": "AS Wilson",
      "first-page": "138",
      "journal-title": "Biochim Biophys Acta",
      "key": "BFhdy201042_CR87",
      "unstructured": "Wilson AS, Power BE, Molloy PL (2007). DNA hypomethylation and human diseases. Biochim Biophys Acta 1775: 138–162.",
      "volume": "1775",
      "year": "2007"
    },
    {
      "DOI": "10.1126/science.1089523",
      "author": "AS Yang",
      "doi-asserted-by": "crossref",
      "first-page": "1153",
      "journal-title": "Science",
      "key": "BFhdy201042_CR88",
      "unstructured": "Yang AS, Estecio MR, Garcia-Manero G, Kantarjian HM, Issa JP (2003). Comment on ‘Chromosomal instability and tumors promoted by DNA hypomethylation’ and ‘Induction of tumors in nice by genomic hypomethylation’. Science 302: 1153; author reply 1153.",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-4068",
      "author": "D Yang",
      "doi-asserted-by": "crossref",
      "first-page": "3301",
      "journal-title": "Cancer Res",
      "key": "BFhdy201042_CR89",
      "unstructured": "Yang D, Thangaraju M, Greeneltch K, Browning DD, Schoenlein PV, Tamura T et al. (2007). Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res 67: 3301–3309.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nrd1930",
      "author": "CB Yoo",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "journal-title": "Nat Rev Drug Discov",
      "key": "BFhdy201042_CR90",
      "unstructured": "Yoo CB, Jones PA (2006). Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5: 37–50.",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.pcad.2007.02.004",
      "author": "PP Young",
      "doi-asserted-by": "crossref",
      "first-page": "421",
      "journal-title": "Prog Cardiovasc Dis",
      "key": "BFhdy201042_CR91",
      "unstructured": "Young PP, Vaughan DE, Hatzopoulos AK (2007). Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 49: 421–429.",
      "volume": "49",
      "year": "2007"
    }
  ],
  "reference-count": 91,
  "references-count": 91,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/hdy201042"
    }
  },
  "score": 0,
  "short-container-title": [
    "Heredity"
  ],
  "source": "Crossref",
  "title": [
    "Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy"
  ],
  "type": "journal-article",
  "volume": "105"
}